The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Life Insurance Corporation of India (LIC), a domestic institutional investor and not part of the promoter group, has filed a revised disclosure under SEBI Takeover Regulations regarding its holding in Divis Laboratories. LIC sold approximately 53.54 lakh shares (2.017% of equity) through the open market between 7 November 2022 and 16 October 2025. As a result, LIC's stake has come down from 5.033% (1.33 crore shares) to 3.016% (80.06 lakh shares), taking it below the 5% disclosure threshold. The total equity share capital of the company remained unchanged at about 53.09 crore shares. This is a revised filing updating the earlier disclosure, with the sale value running into several hundred crores based on Divis's trading price during the period.
A large domestic institutional investor trimming its holding below the 5% mark is mildly negative for sentiment, indicating reduced institutional conviction, though the sales were spread over nearly three years rather than being a sudden block deal. For retail investors, this is mainly an informational disclosure and is unlikely to cause immediate price pressure since the trades have already happened.